Search Within

Dmitriy Zamarin

  1. "2019"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (4)
  3. Editorial (2)
  4. Guidelines (1)
Groups
  1. Department of Medicine (14)
  2. GDMT, Medicine (14)
  3. Gynecologic Medicine Service (14)
  4. Gynecology Disease Management Team (14)
  5. Solid Tumor Oncology Division (14)
  6. Hematologic Malignancies, Division of (7)

More Groups

People
  1. Carol Aghajanian (6)
  2. Roisin O'Cearbhaill (6)
  3. Jason Konner (5)
  4. Alexia Iasonos (4)
  5. Claire Friedman (4)
  6. Karen Cadoo (4)

More People

Years
  1. 2019 (14)
Publications
  1. Journal of Clinical Oncology (3)
  2. Clinical Cancer Research (2)
  3. Gynecologic Oncology (2)
  4. International Journal of Gynecological Cancer (2)
  5. JCO Precision Oncology (1)
  6. Journal for ImmunoTherapy of Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (2)
  3. Elsevier Inc. (2)
  4. Lippincott Williams & Wilkins (2)
  5. Nature Publishing Group (2)
  6. Biomed Central Ltd (1)

More Publishers

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Computed tomography-derived radiomic metrics can identify responders to immunotherapy in ovarian cancer
    Journal Article

    Himoto, Y.; Veeraraghavan, H.; Zheng, J.; Zamarin, D.; Snyder, A.; Capanu, M.; Nougaret, S.; Vargas, H. A.; Shitano, F.; Callahan, M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • A phase 2 study of TPIV200/ huFR-1 (a multi-epitope folate receptor alpha vaccine) in combination with durvalumab in patients with platinum resistant ovarian cancer
    Meeting Abstract

    Zamarin, D.; Yeku, O.; O'Cearbhaill, R. E.; Cadoo, K. A.; Gallagher, J.; Kravetz, S.; McDonnell, A.; Troso-Sandoval, T.; Sabbatini, P.; Lichtman, S.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Blockade of IDO/TDO downstream effectors restricts a Treg-macrophage suppressive axis and resistance to anti-PD-1 therapy
    Meeting Abstract

    Campesato, L.; Budhu, S.; Tchaicha, J.; Gigoux, M.; Cohen, I.; Mangarin, L.; Redmond, D.; Pourpe, S.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: Final results
    Meeting Abstract

    Grisham, R.; Giri, D.; Henson, M.; Iasonos, A.; Zhou, Q.; McDonnell, A.; Girshman, J.; O'Cearbhaill, R.; Zamarin, D.; Aghajanian, C.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Immunomodulatory drugs encoded by oncolytic viruses: Is the whole greater than the sum?
    Editorial

    Zamarin, D.
    Molecular Therapy (2019)

    Fulltext@MSK | Save
  • A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma
    Meeting Abstract

    Rubinstein, M. M.; Caird, I.; Zhou, Q.; Iasonos, A.; Friedman, C. F.; Cadoo, K. A.; Konner, J. A.; O'Cearbhaill, R. E.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of pembrolizumab in patients with advanced adrenocortical carcinoma
    Meeting Abstract

    Raj, N. P.; Zheng, Y.; Kelly, V.; Katz, S.; Chou, J. F.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Ariyan, C. E.; Untch, B. R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Response to immune checkpoint inhibition and survival in BRCA-associated recurrent ovarian cancer
    Meeting Abstract

    Liu, Y. L.; Boland, J. L.; Cadoo, K. A.; Friedman, C. F.; Konner, J. A.; O'Cearbhaill, R. E.; Aghajanian, C.; Zamarin, D.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer
    Journal Article

    Liu, Y. L.; Zhou, Q.; Iasonos, A.; Emengo, V. N.; Friedman, C.; Konner, J. A.; O'Cearbhaill, R. E.; Aghajanian, C.; Zamarin, D.
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Novel therapeutics: Response and resistance in ovarian cancer
    Meeting Abstract

    Zamarin, D.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save